Otsuka Holdings Co., Ltd. (OTSKF)

40,88 0,00 (0,00 %) À partir de 03:10PM EDT. Marché ouvert.

Otsuka Holdings Co., Ltd.

2-9 Kanda-Tsukasamachi
Chiyoda-ku
Tokyo 101-0048
Japan
81 3 6717 1410
https://www.otsuka.com

Secteur(s): Healthcare
Secteur d’activité: Drug Manufacturers - General
Employés à temps plein: 34 388

Dirigeants clés

Nom	Titre	Payer	Exercé	Année de naissance
Mr. Tatsuo Higuchi	CEO, President & Representative Director	1,41M	S.O.	1950
Mr. Makoto Inoue	COO & Representative Director	742,4k	S.O.	1958
Mr. Yoshiro Matsuo	Executive Deputy President & Executive Director	601,6k	S.O.	1960
Mr. Masayuki Kobayashi	Executive Director	723,2k	S.O.	1966
Ms. Yuko Makino	CFO & Executive Director	S.O.	S.O.	1961
Akiko Ryu	Senior VP & Director of Human Resource Planning Department	S.O.	S.O.	S.O.
Ms. Noriko Tojo	Executive Director	460,8k	S.O.	1964
Mr. Shuichi Takagi	Executive Director	S.O.	S.O.	1966
Chiaki Sakurai	Senior Vice President of Nutraceutical Business, Global Strategy & Planning Headquarters	S.O.	S.O.	S.O.
Shigeko Takahashi	Senior VP and GM of Nutraceutical Business, Global Strategy & Planning Headquarters	S.O.	S.O.	S.O.

Les montants ont été établis en date du 31 décembre 2022 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, and insecticide and toiletry products. In addition, the company offers IT solution services; adhesive tapes; flaky titanate and compounds; IV solutions; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; urinary tract health products; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. Otsuka Holdings Co., Ltd. was founded in 1921 and is headquartered in Tokyo, Japan.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Otsuka Holdings Co., Ltd. en date du 1 mai 2024 est 8. Les scores principaux sont Audit : 1; Société : 8; Droits des actionnaires : 10; Compensation : 1.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.